Maxim Group logo

Maxim Group

North America, New York, United States, New York

Description

Maxim Group is a full-service firm that offers investment banking, and securities and wealth management services.

Investor Profile

Maxim Group has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 57% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Israel.
  • Strong thematic focus on Health Care, Biotechnology, Medical.

Stage Focus

  • Post Ipo Equity (29%)
  • Series Unknown (29%)
  • Series A (14%)
  • Series C (14%)
  • Series B (14%)

Country Focus

  • United States (86%)
  • Israel (14%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Genetics
  • Manufacturing
  • 3d Printing
  • Alternative Protein
  • Food Processing
  • Machinery Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Maxim Group frequently co-invest with?

Jefferies
North America, New York, United States, New York
Co-Investments: 1
Civilization Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Retinal Degeneration Fund
North America, North Carolina, United States, Raleigh
Co-Investments: 1
H. C. Wainwright & Co.
North America, New York, United States, New York
Co-Investments: 1
FBR & Co
North America, Virginia, United States, Arlington
Co-Investments: 1
RBC Capital Markets
North America, New York, United States, Albany
Co-Investments: 1
Cantor Fitzgerald
North America, New York, United States, New York
Co-Investments: 1
Foundation Fighting Blindness
North America, Maryland, United States, Columbia
Co-Investments: 1
Celesta Capital
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Maxim Group?

NAYA Biosciences

Sarasota, Florida, United States

NAYA Biosciences is an agile and synergistic platform that provides access to the next generation of biotechnologies.

BiotechnologyBusiness DevelopmentHealth Care
Post Ipo EquityDec 2, 2025
Amount Raised: $4,000,000
Co-Diagnostics

Salt Lake City, Utah, United States

Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.

BiopharmaBiotechnologyHealth CareLife Science
Post Ipo EquityOct 20, 2025
Amount Raised: $10,000,000
Nano Labs

Hangzhou, Zhejiang, China

Nano Labs operates as a chip designer company.

ComputerSemiconductor
Post Ipo EquityAug 21, 2025
Amount Raised: $45,000,000
Steakholder Foods

Rehovot, HaMerkaz, Israel

Steakholder Foods is a leading innovator in alternative proteins production and 3D printing production technologies.

3D PrintingAlternative ProteinBiotechnologyFood ProcessingMachinery Manufacturing
Post Ipo EquityJan 6, 2023
Amount Raised: $6,500,000
Nacuity Pharmaceuticals

Fort Worth, Texas, United States

Nacuity Pharmaceuticals is a pharmaceutical company that aims to develop a breakthrough treatment for retinitis pigmentosa.

Health CarePharmaceutical
Series BJun 15, 2022
Amount Raised: $16,500,000
Alveo Technologies

Alameda, California, United States

Alveo is a pre-clinical stage medical diagnostics company .

Health CareMedicalMedical Device
Series AJan 5, 2018
Amount Raised: $38,000,000
Abeona Therapeutics

New York, New York, United States

Abeona Therapeutics develops gene therapy-based potential cures for Sanfilippo syndrome types A and B.

BiotechnologyGeneticsHealth CareManufacturingMedical Device
Post Ipo EquityOct 19, 2017
Amount Raised: $92,000,000
Edge Therapeutics

Berkeley Heights, New Jersey, United States

Edge Therapeutics, a biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions.

BiotechnologyHealth CareMedical
Series CJun 4, 2013
Amount Raised: $18,000,000
ContraFect

Yonkers, New York, United States

ContraFect is a biotechnology company researching the use of monoclonal antibodies to treat life-threatening infectious diseases.

BiotechnologyHealth CareMedical
Series UnknownSep 15, 2011
Amount Raised: $12,502,905
BillMyParents

San Diego, California, United States

BillMyParents is a shopping system for children to purchase using their parents’ credentials via an email request and approval system.

E-CommerceFinancial ServicesParentingTeenagersYoung Adults
Series UnknownNov 24, 2010
Amount Raised: $3,400,000

Find More Investors Like Maxim Group

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides